Categories: Product News

Solvay to Increase its Hydroquinone and MEHQ Production Capacities

Bengaluru, April 20, 2016: Solvay Aroma Performance, the worldwide leader in diphenol and derivatives intermediates, announces its plan to build an additional production capacity of Hydroquinone (HQ) in China starting-up in 2018. This investment will be based on an innovative and environmental friendly technology.

In addition, the Global Business Unit will extend its worldwide Methyl hydroquinone (MEHQ also referred as PMP – paramethoxyphenol) capacity. Both projects will support Solvay captive needs as well as the growth of HQ and MEHQ markets, particularly in Asia.

“This decision will strengthen the company leading position in growing markets like Monomer inhibition with a full range of solutions including PTZ coming from Cytec acquisition, Specialty polymers and Coatings applications as well as Food & Feed antioxidants on which we are positioning ourselves” says Dominique Rage, President of the GBU. “This major capacity increase enhances our reliability towards our customers and will allow for new growth opportunities” he adds.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

2 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

3 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

3 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

4 days ago